SPAC Daily: Return of Merger Monday

by | Jul 25, 2022

For the first time in recent memory, we had a fairly active SPAC merger Monday with 3 (yes!) 3 new DAs:

  • Frazier Life Sciences Acquisition Corp. (FLAC) and NewAmsterdam Pharma, $326M
  • DUET Acquisition Corp. (DUET) and AnyTech 365, $287M
  • DHC Acquisition Corp. (DHCA) and GloriFi, $1.7B

However, that brings us to GloriFi. Not taking a view on the deal yet (tough to with little information released), though a $1.7B valuation is a bit of head scratcher for a company that feels as if is in a very WIP mode. To boot, this was at the bottom of their Press Release: “Given the Summer Holiday Season, GloriFi intends to Post its Full Investor Presentation After Labor Day”

From GloriFi’s website, looks like most products have yet to launch

That’s definitely a first and doesn’t exactly scream, hey we’re working hard for you. If you can’t even bother to work on a presentation until after Labor Day, what is the point of rushing to announce in July? Watch out high redemptions!

Elsewhere in SPACs

  • Better World Acquisition Corp. (BWAC) set a date for another extension. vote 8/15, out till feb. 44% redeemed in last vote.
  • Abri SPAC (ASPA) and blockchain co Apifiny terminated their previously announced deal. ASPA will look for another target.

Upcoming SPAC Calendar

Full calendar and SPAC database access here

Today’s Price Action

Biggest Gainers

4.16% ~ $ 9.27 | WALD – Waldencast Acquisition Corp. (Announced)
2.49% ~ $ 10.29 | TRON – Corner Growth Acquisition Corp. 2 (Pre-Deal)
.81% ~ $ 9.95 | BCAC – Brookline Capital Acquisition Corp. (Pre-Deal)
.80% ~ $ 10.10 | VMCA – Valuence Merger Corp. I (Pre-Deal)
.71% ~ $ 9.88 | CLAA – Colonnade Acquisition Corp. II (Pre-Deal)
.62% ~ $ 9.73 | HWEL – Healthwell Acquisition Corp. I (Pre-Deal)
.61% ~ $ 9.91 | VBOC – Viscogliosi Brothers Acquisition Corp (Pre-Deal)
.52% ~ $ 9.75 | ALCC – AltC Acquisition Corp. (Pre-Deal)
.52% ~ $ 9.75 | IPAX – Inflection Point Acquisition Corp. (Pre-Deal)
.51% ~ $ 9.83 | GAQ – Generation Asia I Acquisition Ltd (Pre-Deal)
.51% ~ $ 9.90 | IVCP – Swiftmerge Acquisition Corp. (Pre-Deal)
.51% ~ $ 9.94 | FCAX – Fortress Capital Acquisition Corp (Pre-Deal)
.50% ~ $ 10.14 | TOAC – Talon 1 Acquisition Corp (Pre-Deal)
.45% ~ $ 9.99 | DCRD – Decarbonization Plus Acquisition Corp IV (Pre-Deal)
.41% ~ $ 9.70 | JAQC – Jupiter Acquisition Corporation (Pre-Deal)
.41% ~ $ 9.74 | DALS – DA32 Life Science Tech Acquisition Corp. (Pre-Deal)
.41% ~ $ 9.76 | FICV – Frontier Investment Corp (Pre-Deal)
.41% ~ $ 9.76 | DUNE – Dune Acquisition Corporation (Announced)
.41% ~ $ 9.76 | CLBR – Colombier Acquisition Corp. (Pre-Deal)
.41% ~ $ 9.89 | ITQ – Itiquira Acquisition Corp. (Pre-Deal)

Biggest Losers

-5.61% ~ $ 9.42 | CHWA – CHW Acquisition Corp (Announced)
-1.87% ~ $ 31.00 | DWAC – Digital World Acquisition Corp. (Announced)
-1.25% ~ $ 9.48 | NLIT – Northern Lights Acquisition Corp. (Announced)
-1.00% ~ $ 9.91 | GLTA – Galata Acquisition Corp (Pre-Deal)
-.60% ~ $ 9.87 | LCW – Learn CW Investment Corp (Pre-Deal)
-.50% ~ $ 10.00 | PWUP – PowerUp Acquisition Corp. (Pre-Deal)
-.49% ~ $ 10.17 | ACEV – ACE Convergence Acquisition Corp (Announced)
-.44% ~ $ 10.07 | CLAY – Chavant Capital Acquisition Corp. (Pre-Deal)
-.40% ~ $ 9.92 | STET – ST Energy Transition I Ltd. (Pre-Deal)
-.40% ~ $ 10.02 | CFVI – CF Acquisition Corp. VI (Announced)
-.31% ~ $ 9.67 | CDAQ – Compass Digital Acquisition Corp. (Pre-Deal)
-.31% ~ $ 9.70 | BWC – Blue Whale Acquisition Corp I (Pre-Deal)
-.30% ~ $ 9.81 | RACB – Research Alliance Corp. II (Pre-Deal)
-.30% ~ $ 9.82 | LVRA – Levere Holdings Corp (Pre-Deal)
-.30% ~ $ 9.84 | TRIS – Tristar Acquisition I Corp. (Pre-Deal)
-.30% ~ $ 9.93 | GDST – Goldenstone Acquisition Ltd. (Announced)
-.30% ~ $ 9.94 | FATP – FAT PROJECTS ACQUISITION CORP (Pre-Deal)
-.30% ~ $ 9.96 | ALSA – Alpha Star Acquisition Corp (Pre-Deal)
-.30% ~ $ 10.01 | LVAC – LAVA Medtech Acquisition Corp. (Pre-Deal)
-.30% ~ $ 10.04 | LFAC – LF Capital Acquisition Corp. II (Pre-Deal)

Recent Analysis

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.